Related Experiment Video
Updated: Oct 8, 2025

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
[Current understanding and progress of research on isovaleric acidemia]
Yunfei Zhao1, Shasha Zhu, Xinwen Huang
1Department of Genetics and Metabolism, Children's Hospital Affiliated to Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang 310052, China. 630522@zju.edu.cn.
Isovaleric acidemia is a rare, inherited metabolic condition that prevents the body from properly breaking down a specific amino acid. This review examines the clinical signs, ranging from infancy to adulthood, and highlights how timely detection and appropriate management are vital for better patient outcomes.
Area of Science:
- Pediatric metabolic medicine and isovaleric acidemia research
- Clinical genetics and inherited metabolic disorders
Background:
No prior work had resolved the full spectrum of phenotypic variability in this inherited metabolic disorder. Prior research has shown that this condition represents the first organic acidemia identified in clinical practice. That uncertainty drove interest in defining the diverse age of onset for affected individuals. It was already known that genetic transmission follows an autosomal recessive pattern. This gap motivated a comprehensive assessment of the clinical presentation across different life stages. Prior research has shown that symptoms range from acute neonatal distress to chronic cognitive impairment. That uncertainty drove the need for a synthesized overview of current diagnostic and therapeutic standards. No prior work had resolved the specific impact of early intervention on long-term survival rates.
Purpose Of The Study:
The aim of this article is to provide a comprehensive summary of current understanding and research progress regarding this organic acidemia. This review addresses the need to consolidate information on the complex clinical manifestations of the condition. The authors seek to clarify how the age of onset influences the severity of the disease. This work aims to highlight the importance of timely detection in the clinical pathway. The researchers intend to synthesize existing data on the mortality and morbidity associated with this disorder. This article addresses the necessity of rational treatment strategies for improving long-term patient outcomes. The authors aim to bridge the gap between historical diagnostic challenges and modern clinical practices. This review serves to inform healthcare providers about the variable nature of this inherited metabolic condition.
Main Methods:
Review approach involved a systematic synthesis of existing literature regarding this inherited condition. Investigators examined clinical reports spanning from neonatal onset to adult manifestations. Review approach utilized data from diverse patient populations to categorize common symptomatic patterns. Researchers evaluated diagnostic timelines to determine the efficacy of early detection methods. Review approach incorporated analysis of therapeutic interventions and their corresponding prognostic outcomes. Investigators synthesized findings on mortality and morbidity rates reported in previous studies. Review approach focused on consolidating current knowledge to provide a clear overview of the field. Researchers assessed the variability of clinical signs to establish a comprehensive profile of the disease.
Main Results:
Key findings from the literature indicate that this condition represents the earliest identified organic acidemia. Key findings from the literature show that clinical presentations are highly complex and variable among patients. Key findings from the literature reveal that symptoms include feeding difficulties, vomiting, lethargy, and coma. Key findings from the literature report that metabolic acidosis and a sweaty feet odor are characteristic signs. Key findings from the literature demonstrate that mental retardation is a potential long-term consequence of the disorder. Key findings from the literature highlight that mortality and mobility rates are notably high for affected individuals. Key findings from the literature confirm that early diagnosis is vital for improving patient prognosis. Key findings from the literature suggest that rational treatment strategies are effective in managing the disease.
Conclusions:
Synthesis and implications suggest that early detection remains the most effective strategy for improving patient health. The authors indicate that prompt medical management significantly alters the trajectory of this metabolic condition. Synthesis and implications highlight that clinical presentations are highly heterogeneous across the patient population. The authors propose that recognizing characteristic signs, such as specific odors, aids in timely identification. Synthesis and implications confirm that mortality risks are substantial without appropriate therapeutic support. The authors suggest that ongoing monitoring is necessary to manage the complex nature of this disorder. Synthesis and implications underscore that research progress continues to refine our approach to patient care. The authors conclude that further investigation into long-term outcomes will benefit clinical practice.
Frequently Asked Questions
The researchers propose that the condition arises from an autosomal recessive inheritance pattern. This mechanism disrupts the breakdown of specific amino acids, leading to the accumulation of toxic metabolites, which contrasts with other organic acidemias that involve different enzymatic pathways.
The authors identify clinical indicators including feeding difficulties, vomiting, lethargy, and a distinct sweaty feet odor. These signs differ from general metabolic distress, which often presents only with non-specific symptoms like lethargy or vomiting.
The authors state that early diagnosis is necessary to improve prognosis. This requirement is distinct from later-onset cases where the disease might be managed differently, as neonatal presentations often require immediate intervention to prevent coma or metabolic acidosis.
The researchers utilize clinical data to characterize the disease. This information role is to bridge the gap between initial symptomatic presentation and long-term developmental outcomes, unlike molecular data which focuses purely on genetic mutation identification.
The authors measure the impact of treatment through prognosis improvement. This phenomenon is observed when rational therapeutic strategies are applied, contrasting with untreated cases that frequently result in higher mortality or significant mental retardation.
The researchers propose that rational treatment strategies are essential for better outcomes. This implication suggests that standardized care protocols are superior to reactive management, as they address the metabolic instability inherent in the disease.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Acidity of Carboxylic Acids
Inborn Errors of Metabolism
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Carboxylic Acid Derivatives: Overview

